Opko Health Inc (OPK) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Opko Health Inc (OPK) has a cash flow conversion efficiency ratio of -0.037x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-43.50 Million) by net assets ($1.18 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see OPK company net worth for the company's overall valuation and market capitalisation.
Opko Health Inc - Cash Flow Conversion Efficiency Trend (1995–2025)
This chart illustrates how Opko Health Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Opko Health Inc (OPK) stock price for real-time trading data and today's change.
Opko Health Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Opko Health Inc ranked by their cash flow conversion efficiency. Review cash generation quality of Opko Health Inc to assess how much free cash flow the company generates relative to operating cash flow.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Sensirion Holding AG
SW:SENS
|
0.104x |
|
Blue Dart Express Limited
NSE:BLUEDART
|
0.152x |
|
Chongqing Department Store Co Ltd
SHG:600729
|
0.066x |
|
Bolsa Mexicana de Valores S.A.B. de C.V
MX:BOLSAA
|
0.070x |
|
Fujian Dongbai Group Co Ltd
SHG:600693
|
0.036x |
|
Zhejiang Wanliyang Transmission Co Ltd
SHE:002434
|
0.066x |
|
Vossloh AG
F:VOS
|
-0.046x |
|
Cadre Holdings Inc
NYSE:CDRE
|
0.067x |
Annual Cash Flow Conversion Efficiency for Opko Health Inc (1995–2025)
The table below shows the annual cash flow conversion efficiency of Opko Health Inc from 1995 to 2025. Also see Opko Health Inc balance sheet assets for a full breakdown of the balance sheet.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $1.27 Billion | $-178.54 Million | -0.141x | -4.79% |
| 2024-12-31 | $1.37 Billion | $-183.49 Million | -0.134x | -562.07% |
| 2023-12-31 | $1.39 Billion | $-28.20 Million | -0.020x | +66.70% |
| 2022-12-31 | $1.56 Billion | $-95.19 Million | -0.061x | -367.93% |
| 2021-12-31 | $1.69 Billion | $38.34 Million | 0.023x | -3.67% |
| 2020-12-31 | $1.67 Billion | $39.48 Million | 0.024x | +122.10% |
| 2019-12-31 | $1.61 Billion | $-172.52 Million | -0.107x | -75.35% |
| 2018-12-31 | $1.79 Billion | $-109.14 Million | -0.061x | -21.99% |
| 2017-12-31 | $1.84 Billion | $-92.08 Million | -0.050x | -426.02% |
| 2016-12-31 | $2.09 Billion | $32.05 Million | 0.015x | -81.51% |
| 2015-12-31 | $1.98 Billion | $164.02 Million | 0.083x | +176.62% |
| 2014-12-31 | $835.80 Million | $-90.38 Million | -0.108x | -62.22% |
| 2013-12-31 | $872.98 Million | $-58.19 Million | -0.067x | +46.68% |
| 2012-12-31 | $203.28 Million | $-25.41 Million | -0.125x | -8.73% |
| 2011-12-31 | $160.88 Million | $-18.50 Million | -0.115x | +86.12% |
| 2010-12-31 | $23.05 Million | $-19.09 Million | -0.828x | -104.90% |
| 2009-12-31 | $57.73 Million | $-23.34 Million | -0.404x | +99.50% |
| 2008-12-31 | $359.00K | $-29.29 Million | -81.599x | -7980.45% |
| 2007-12-31 | $16.78 Million | $-16.95 Million | -1.010x | -2574.56% |
| 2006-12-31 | $8.08 Million | $-305.00K | -0.038x | +63.28% |
| 2005-12-31 | $8.72 Million | $-897.00K | -0.103x | +36.41% |
| 2004-12-31 | $9.83 Million | $-1.59 Million | -0.162x | +71.45% |
| 2003-12-31 | $10.30 Million | $-5.84 Million | -0.566x | -3.00% |
| 2002-12-31 | $16.07 Million | $-8.84 Million | -0.550x | -79.44% |
| 2001-12-31 | $26.12 Million | $-8.01 Million | -0.306x | -119.84% |
| 2000-12-31 | $35.77 Million | $-4.99 Million | -0.139x | +88.80% |
| 1999-12-31 | $2.59 Million | $-3.23 Million | -1.245x | -216.43% |
| 1998-12-31 | $6.10 Million | $-2.40 Million | -0.393x | +85.08% |
| 1997-12-31 | $1.10 Million | $-2.90 Million | -2.636x | -142.55% |
| 1996-12-31 | $2.30 Million | $-2.50 Million | -1.087x | -171.74% |
| 1995-12-31 | $5.00 Million | $-2.00 Million | -0.400x | -- |
About Opko Health Inc
OPKO Health, Inc. operates as a healthcare company, in the United States, Ireland, Chile, Spain, Israel, Mexico, and internationally. The company operates in two segments, Pharmaceutical and Diagnostics. The Pharmaceutical segment develops MDX2001, a tetra-specific antibody targeting several types of solid tumors in Phase 1 clinical trials; MDX2003, a tetra-specific antibody targeting two antigen… Read more